Categories
Technology News

After Scotland says no, NICE backs Lilly’s Retsevmo for lung cancer – – Pharmaphorum

The recommendation from health technology assessment (HTA) agency NICE comes a couple of weeks after Retsevmo (selpercatinib) was cleared for use …